Lifestyle programmes delivered by academic nursecounsellors in a primary care setting lowered blood pressure (BP) among at-risk patients. We examined whether the programmes could be successfully implemented by nurses employed in Australian general practices. In a randomised controlled trial, 212 of 591 eligible 20-75-year olds with hypertension, Type II diabetes or coronary disease from seven practices volunteered. Patients were randomised to: a 'Low' group with one face-to-face individual counselling session, then monthly telephone contacts for 1 year (n ¼ 69); a 'High' group with individual face-to-face counselling up to 1 h monthly for 1 year (n ¼ 74) or a control group receiving usual care only (n ¼ 69), and were evaluated at baseline and 12 and 18 months later; 164 individuals completed the study. Patients' usual doctors continued to prescribe in all groups. Changes in 24 h ambulatory BP did not differ significantly between groups at 12 months (Low, À2 7 2/1 7 1 mmHg; High, +4 7 2/1 7 1 mmHg; usual care, +1 7 2/1 7 1 mmHg) or 18 months (À2 7 2/2 7 1 mmHg; À4 7 2/3 7 2 mmHg; À1 7 2/2 7 1 mmHg, respectively). Antihypertensive drugs prescribed decreased by 12 months in 33% of the High, 5% of the Low and 13% of the control groups (P ¼ 0.008) and by 36, 7 and 16% at 18 months (P ¼ 0.018). After 18 months, targets for BP control were not met in about 60% of patients and almost 50% had clinic BP above 140/ 90 mmHg. Year-long interaction with nurse-counsellors may influence longer-term antihypertensive drug prescription, possibly by improving compliance. Suboptimal BP control suggests that continuing physician education on BP targets is needed.
Introduction
Lowering of blood pressure (BP) in hypertensive patients may be achieved by nonpharmacological measures 1 that include weight control, increased fruit and vegetable intake and substitution of saturated fats with low-fat dairy products, decreased sodium intake, increased dietary fish or fish oil, increased physical activity and decreased alcohol consumption. Combinations of these interventions may have additive effects.
Although reduction of multiple risk factors is optimal in the management of hypertension, intervention programmes with this aim have had varied success in primary care settings. A systematic review of such trials 2 found modest changes in risk factors with an overall significant fall in BP. Secondary prevention trials have reported more substantial changes, 3 suggesting that the greatest benefit is likely in high-risk patients. 4 Lifestyle programmes at a primary care level have used a range of strategies for counselling and education. Steptoe et al 5 reported that counselling appropriate to an individual's readiness to change behaviour 6 could improve health-related behaviours, but found no change in cardiovascular risk factors. We found that a cognitive behavioural programme presented by two 'academic' nurses trained in counselling techniques and aiming to reduce multiple risk factors among treated hypertensive patients in general practice, led to a fall in clinic BP accompanied by weight loss. 7 In the present study, we aimed to examine whether this programme could be successfully conducted by nurses already working in primary care practices in Perth, Western Australia, focusing on patients at high risk of cardiovascular disease. The programme encouraged weight reduction, increased physical activity, reduced dietary saturated fat, sodium and alcohol, increased intake of fish, fruit and vegetables and stopping smoking. Here, we describe the effects, 12 and 18 months after enrolment in the programme, on clinic and ambulatory BP (ABP), which were primary outcomes, and prescription of antihypertensive drugs that was examined in post hoc analysis.
Materials and methods

Participants
Patients were identified from practice records in seven Perth general practices, selected from a range of socioeconomic areas, already employing nurses. Patients 20-75 years old with hypertension (systolic BP (SBP) greater than 140 mmHg and/or diastolic BP (DBP) greater than 90 mmHg or being treated with antihypertensive drugs), Type II diabetes mellitus or coronary heart disease were invited to volunteer. Eligible patients who did not respond to the initial invitation were contacted a second time by letter or telephone to encourage participation. All participants gave written informed consent and the Human Rights Committee of the University of Western Australia approved the study.
Intervention programme
Block randomisation stratified by gender and age was used to allot patients to one of three groups. In the control group, patients remained under the care of their general practitioner and had no additional intervention. The low-level group received an initial individual face-to-face counselling and were then contacted by telephone (10-15 min consultations) monthly for 1 year. The high-level group was counselled in individual face-to-face sessions up to 1 h monthly over 1 year. Each general practitioner continued to manage their patients according to their own usual methods and no protocol for drug management of hypertension was imposed in the study. General practitioners were blinded to the group allocation of their patients and prescribed drugs without reference to nurses' BP recordings or ABP measurements. The programme has been described elsewhere. 8 Practice nurses were necessarily aware of the allocation of patients to intervention groups, but measurement of clinic and ABP was automated and dietary data were collected independent of these nurses. However, weight, waist and hip circumferences were recorded by the nurse-counsellors.
Baseline and follow-up assessments
At baseline and after 12 and 18 months, measurements included height, weight, waist and hip circumferences and clinic BP measured using a Dinamap 1846 SX/P (Critikon) every 2 min for 10 min after sitting quietly for 5 min. ABP was recorded over 24 h at baseline, 12 and 18 months (Accutracker II, Suntech Model 104). For ABP all participants were asked to take part in the 24 h monitoring, but refusal to undergo monitoring resulted in 50 participants in the control group, 50 in the low-level group and 46 in the high-level intervention group at baseline. At each assessment, urinary sodium and potassium were measured using 24 h urine collections, dietary intake was recorded using the Deakin food frequency questionnaire (FFQ), 9 physical activity was assessed by a 7-day recall questionnaire 10 and plasma fatty acids were measured 11 to allow determination of the ratio of n3 to n6 fatty acids as an indication of changes in fish consumption.
Statistical methods
The sample size was estimated based on findings from our earlier study, 7 aiming to detect a difference of 2.5 kg in body weight with an alpha level of 0.05 and a power of 95% allowing for a 25% dropout rate. We previously found a dropout rate of 18%. With ABP as the outcome, with a sample size of 70 per group, Po0.05 and a power of 80%, a betweengroup difference of 8 mmHg in SBP was detectable. Data were analysed using a random effects mixed model (Proc Mixed, SAS V8, SAS Institute, Cary, NC, USA) adjusted for the source of the patients, age, gender, antihypertensive drug treatment, alcohol intake and urinary sodium. Additional adjustment for the presence of Type II diabetes or coronary disease did not affect the interpretation of the models. The Bonferroni adjustment was used to account for multiple comparisons. Results were considered significant at the 5% level.
Results
Subjects
Of 591 eligible patients invited to participate, 212 attended the initial assessment and were randomly assigned to one of the three treatment groups (Control n ¼ 69; 'Low' n ¼ 69; 'High' n ¼ 74) (see Figure 1 for flow diagram). For ABP, there were 50 participants in the control group, 50 in the low-level group and 46 in the high-level intervention at baseline. Numbers decreased to 34, 34 and 37, respectively, at 12 months and to 27, 32 and 24, respectively, at 18 months, because of unwillingness to undergo ABP monitoring (ABPM), change of address and failure to keep appointments despite repeated attempts to encourage attendance. At baseline, the treatment groups differed significantly only in BMI and weight (Table 1) , and in the lower proportion of smokers in the High intervention group. There were no significant differences at baseline related to attendance or nonattendance at the 12 or 18 month follow-up visits.
BP and heart rate
Changes from baseline in clinic BP did not differ significantly between treatment groups at 12 or 18 months. At 12 months, BP changed (SBP/DBP) by +0.6(2.5)/À0.1(1.1) mmHg in the usual care group, +6.4(2.6)/+0.7(1.3) mmHg in the low-level group and +5.0(2.8)/+0.3(1.3) mmHg in the high-level group (SBP, P ¼ 0.654; DBP P ¼ 0.264). At 18 months, the changes were +0.2(2.6)/À0.7(1.2) mmHg in the usual care group, À0.9(2.8)/À2.0(1.3) mmHg in the lowlevel group and -3.1(3.1)/À1.8(1.4) mmHg in the high-level group (SBP, P ¼ 0.694; DBP, P ¼ 0.768). Interpretation was unaffected by adjustment for age, sex, antihypertensive drug treatment, general practice, alcohol intake, diabetes or coronary heart disease.
ABP showed no significant treatment effects with mean 24 h SBP (P ¼ 0.314) or DBP (P ¼ 0.524). Although there was a trend for lower SBP, DBP and heart rate in the high-level group at the 18 months assessment (Table 2 ), the smaller number of patients who underwent ABPM at 18 months reduced power to recognise treatment effects. There was no significant between-group effect for awake SBP (P ¼ 0.234) or DBP (P ¼ 0.402), or asleep SBP (P ¼ 0.424) or DBP (P ¼ 0.619), or mean 24 h heart rate (P ¼ 0.974) with or without adjustment for b-blockers.
Patients were classified in relation to the treatment target of 130/85 12 based on clinic BP. In the control group, 63% of patients exceeded this target Nurse-counselling and blood pressure J Woollard et al at baseline, 64% at 12 months and 65% at 18 months. Respective values for the low-level group were 59, 74 and 59% and for the high-level intervention the values were 61, 67 and 59%. There were no significant between-group differences in the proportion of patients not achieving this target. Patients were also classified with reference to hypertension using the definition of 140/90 for clinic BP. 12 In the control group, there were 46% of patients with BP above this level at baseline, 49% at 12 months and 58% at 18 month follow-up. In the low-level group, respective values were 48, 62 and 47% and for the high-level group the values were 38, 55 and 39%. These proportions did not differ significantly between groups. Table 3 shows changes in BMI, weight, physical activity, energy intake, fibre consumption (as an indicator of fruit and vegetable intake), alcohol intake, fasting blood sugar, glycated haemoglobin and urinary sodium and potassium according to treatment group. None was statistically significant. In univariable regression, change in clinic SBP between baseline and 12 months was negatively predicted by change in physical activity (regression coefficient (b ¼ À0.27, se ¼ 0.12, P ¼ 0.026, R 2 ¼ 0.033), and positively by change in energy intake (b ¼ 1.37, se ¼ 0.64, P ¼ 0.034, R 2 ¼ 0.034) and change in sodium excretion (b ¼ 0.43, se ¼ 0.17, P ¼ 0.015, R 2 ¼ 0.045). Relationships were similar for DBP. In stepwise regression, only change in urinary sodium entered the model predicting change in SBP at 12 months, while change in DBP at 12 months was significantly predicted independently by change in physical activity and change in sodium excretion.
Associations between BP, drug treatment and other variables
Change in clinic SBP or DBP between baseline and 18 months was not significantly predicted by change in physical activity, sodium excretion, alcohol intake or fibre consumption (data not shown), but change in DBP at 18 months was significantly related to change in alcohol intake (b ¼ 0.23, se ¼ 0.09, P ¼ 0.014, R 2 ¼ 0.047). There were no significant associations between change from baseline in clinic SBP or DBP and age, sex, change in BMI, weight, waist-to-hip ratio, plasma n3 : n6 fatty acid ratio or urinary potassium at the 12 or 18 month assessments. Change in ABP was unrelated to age and sex and did not correlate significantly with any of these variables. Only one participant, randomised to usual care, quit smoking, and smoking status was not examined as a predictor of change in BP. Table 4 shows the distribution of antihypertensive agents; 64% of treated hypertensive patients were prescribed a single agent with only 9% receiving three or more drugs. Neither the type of drug nor the use of multiple drugs differed significantly between groups ( Table 5) . The proportion of patients who stopped or reduced the dose of antihypertensive drugs was significantly greater in the high-level intervention group at 12 months (P ¼ 0.008) and at 18 months (P ¼ 0.018) ( Table 5 ). In logistic regression, decrease in drug prescription was not predicted significantly by age, sex, change in weight, physical activity, alcohol intake, energy intake, fibre consumption, plasma n3 to n6 ratio or urinary electrolytes.
Antihypertensive drugs
Discussion
In this randomised controlled trial, no statistically significant change in clinic BP or ABP was detected following the intervention. Although there was a trend to lower clinic and ABP in the high-level group at 18 months, these changes were not statistically significant. At 12 months, there was no such trend and, at that time, BP tended to increase more in the intervention groups than in the usual care group. A reduction in the number or dose of antihypertensive drugs prescribed by the patients' general practitioners, when assessed 12 and 18 months after beginning the study, was significantly associated with the high-level intervention. Changes in lifestyle targeted by the intervention programme did not significantly predict changes in drug treatment in the intervention groups. However, possibly small beneficial effects on multiple prohypertensive behaviours may have influenced BP control. In regression models, independent of treatment group, beneficial effects on BP of increased physical activity, and adverse effects of increased intake of salt and energy were recognised at 12 months. At 18 months, a positive association between alcohol intake and DBP was the only significant association with lifestyle to be identified in the participants overall.
The reduction in drugs prescribed arose from decisions by the patients' doctors blinded to the nurses' ABP and clinic BP readings. Although it is possible that doctors responded to patients' demands to reduce drugs, they do not usually reduce drugs unless BP falls substantially and/or patients have symptomatic hypotension. However, the lack of a significant fall in BP could be explained by titration of drug dosage by the patients' own doctors. Control of hypertension may have improved in the high intervention group but, at the end of the study, about 60% of all participants had levels of clinic BP that exceeded the target for control of hypertension and almost half had BP in the hypertensive range. This suggests that the general practitioners who were managing these patients were not achieving optimal control and reduction of drug treatment may have been inappropriate.
Improved compliance with prescribed drugs is a possible explanation for the decrease in antihypertensive drug prescriptions in the high-level group who had the opportunity for face-to-face contact with nurse-counsellors for up to 1 h each month over 1 year. The interaction between hypertensive patients and nurse-counsellors may be important in promoting adherence to treatment 13 and it is possible that the excellent relationships developed between practice nurses and participants influenced compliance. However, we did not measure compliance with drug treatment.
Failure to comply with antihypertensive treatment is common [14] [15] [16] [17] [18] and affects both control of BP and end-organ damage. Cost-benefit estimates suggest that better compliance with treatment would lead to large gains in effectiveness of treating hypertension. 19 While the role of compliance in the present study is speculative, our findings suggest that similar studies should include compliance as an outcome measure.
The sample size estimate for the present study was based on our previous trial of the programme. 7 In that 18-week study, there was a statistically significant fall of 4/3 mmHg in BP and weight loss of 1.75 kg in a high-level group relative to controls. Using previous ABP data, a fall of 4 mmHg in SBP would have been detectable with 80% power and a P-value of 0.05 with a sample size of 63 patients. Attrition of patients reluctant to undergo ambulatory monitoring reduced the sample size to a level at which a difference of 8 mmHg would have been detectable.
We found no significant between-group differences in blood lipids nor in estimated dietary fat intake, although all groups, including the controls, showed improvements in these variables. 8 These data suggest that the intensive, and expensive, additional counselling provided by practice nurses was no more effective in modifying major risk factors and risk behaviours than usual care provided by an interested general practitioner. Our finding of reduced prescription of antihypertensive drugs in the high-level group did not relate to significant between-group differences in health behaviours, suggesting that some other aspect of the programme was responsible. Increased compliance with treatment is a possible explanation and, as improved compliance is potentially a cost-effective way to improve control of BP, 19 it is important to establish Nurse-counselling and blood pressure J Woollard et al whether this can be effected by counselling from practice nurses. Reduction in drug dosage would have important implications for quality of life in individual patients and for costs of health care to the community. However, more than half of the patients, overall, had not achieved target levels of BP control at the end of the study, suggesting that doctors need to use more, or more appropriate, antihypertensive drugs as well as reinforcing lifestyle messages.
